Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-06-02 @ 12:00 AM
Study NCT ID:
NCT05094804
Status:
UNKNOWN
Last Update Posted:
2023-11-02
First Post:
2021-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Sponsor:
OncoResponse, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OR2805-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None